BioStem acquires BioTissue's surgical and wound care assets in $40m deal [Yahoo! Finance]
COLOPLAST AS SP/ADR (CLPBY)
NASDAQ:AMEX Investor Relations:
coloplast.com/investor-relations
Company Research
Source: Yahoo! Finance
BioStem will outlay an upfront cash payment of $15m to acquire the Florida-based company's unit, which includes products such as Neox and Clarix cryopreserved amniotic membrane allografts. The deal includes potential milestone payments of up to $10m for achieving US Food and Drug Administration (FDA) clearance for an unspecified pipeline product, and $15m for additional commercial milestones. BioTissue's Neox and Clarix are positioned as complementary products to BioStem's existing dehydrated amniotic-derived allograft offerings such as the AmnioWrap allograft for chronic and acute wound care. BioStem said the assets will help advance the company's access to chronic and acute wound care markets in hospital inpatient, outpatient, and ambulatory surgery centre settings. Neox is designed for chronic and acute wound applications, while Clarix is intended for surgical applications such as tendon repair and nerve protection. The allografts are derived from human amniotic and umbilical
Show less
Read more
Impact Snapshot
Event Time:
CLPBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLPBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLPBY alerts
High impacting COLOPLAST AS SP/ADR news events
Weekly update
A roundup of the hottest topics
CLPBY
News
- Paralyzed Veterans of America to Host Annual Wheelchair Rugby Invitational in Louisville, Kentucky For Second Consecutive Year - Largest Wheelchair Rugby Event in the U.S. [Yahoo! Finance]Yahoo! Finance
- Coloplast A/S (OTCMKTS:CLPBY) was upgraded by analysts at Sanford C. Bernstein to a "hold" rating.MarketBeat
- 3Shape appoints Rasmus Hannemann as Senior Vice President, Portfolio & Product Strategy [Yahoo! Finance]Yahoo! Finance
- 3 European Stocks Estimated To Be Up To 49.9% Below Intrinsic Value [Yahoo! Finance]Yahoo! Finance
- Coloplast - Premium Valuation And Pedestrian Results Have Been A Bad Mix [Seeking Alpha]Seeking Alpha
CLPBY
Analyst Actions
- 1/29/26 - Sanford C. Bernstein